HYSQX | RITFX | HYSQX / RITFX | |
Total Expense Ratio | 0.70 | 0.38 | 184% |
Annual Report Gross Expense Ratio | 0.72 | 0.38 | 189% |
Fund Existence | 11 years | 23 years | - |
Gain YTD | 6.370 | 7.273 | 88% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 250 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 5.16B | 26.1B | 20% |
Annual Yield % from dividends | 6.72 | 6.57 | 102% |
Returns for 1 year | 6.63 | 7.78 | 85% |
Returns for 3 years | 28.87 | 35.38 | 82% |
Returns for 5 years | 31.97 | 40.89 | 78% |
Returns for 10 years | 68.67 | 86.71 | 79% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
PRIUX | 23.31 | 0.21 | +0.91% |
T. Rowe Price International Stock I | |||
FTDZX | 161.04 | 1.22 | +0.76% |
Franklin Biotechnology Discovery Adv | |||
KCVSX | 18.79 | 0.06 | +0.32% |
Knights of Columbus Large Cap Value S | |||
BIALX | 30.42 | 0.06 | +0.20% |
Brown Advisory Global Leaders Investor | |||
OBGIX | 35.31 | -0.25 | -0.70% |
Oberweis Global Opportunities Instl |